In patients with ALS, high levels of glutamate have been detected in the cerebrospinal fluid (CSF), as well as low expression levels of the EAAT2 glutamate transporter, although whether this is the cause of MN death or a consequence remains debated [30,31,32]. Here, SLC1A2 is linked to amyotrophic lateral sclerosis.